University of Ioannina Launches Groundbreaking MSc in Digital Health in Greece
'We remain committed to providing distinctive global experiences and training that enhance the international credentials'— DImitris I. Fotiadis
IOANNINA, IOANNINA, GREECE, June 12, 2025 / EINPresswire.com / -- University of Ioannina Launches Groundbreaking MSc in Digital Health in Greece. The University of Ioannina proudly announces the launch of its cutting-edge, two-year full-time MSc program in Digital Health, inviting future innovators and leaders to shape the next era of healthcare. An innovative MA in digital health unveiled three of the most prestigious academic institutions of Greece, located in two key cultural and economic centers: Ioannina and Crete. The Department of Materials Science and Engineering of University of Ioannina has partnered with the Medical School and the Biomedical Research Institute - Foundation for Research and Technology – Hellas (FORTH) to offer a high quality program on two strategic and complementary fields: Data experts in Health and Digital Health Transformation.
The MSc program aims to impart the multidisciplinary knowledge and abilities required to spur innovation in the rapidly expanding field of digital health and is designed for professionals in their early or later career stages, as well as students who just graduated. It accepts students from various fields such as Medical Sciences (B.Med.Sc.), Pharmacology, Exact sciences, Engineering schools and Schools of Economics.
Designed to prepare future global leaders, the new MSc in Digital Health Dual Degree in offers an outstanding academic foundation in both management and technology, along with a meaningful international experience. This will enable students not only to acquire new knowledge but also to build a broad and diverse network within three leading academic communities.
The program is distinct from other master's program as it offers the opportunity to enroll in five in-demand fields like Foundation of Digital Health and Informatics, Information and Communication Technologies (ICT), Data Science, Data-driven Decision-making in Healthcare, Healthcare Research, Ethics, and Digital Transformation. Also the program stands out from other Master's degrees as it is part of the prestigious European initiative DS4Health—a collaborative project involving six renowned institutions: NOVA University Lisbon, RWTH Aachen University, the University of Ioannina, Tel Aviv University, Institut Polytechnique de Paris, and the University of Vienna. This strategic alliance fosters interdisciplinary innovation and academic excellence across borders.
'The launch of this new program in partnership with the Medical School of Ioannina and the Biomedical Research Institute - Foundation for Research and Technology – Hellas (FORTH), a world-renowned institution with a long tradition of academic excellence, represents another step in consolidating Department's of Materials Science and Engineering of University of Ioannina international offerings,' said Professor Dimitris Fotiadis, program director. 'We remain committed to providing distinctive global experiences and training that enhance the international credentials of our students and expand their opportunities in the global and multicultural job market, in strategic and innovative areas of digital health'
The MSc in Digital Health is a two-year full time MSc program (four semesters), offering a total of 120 ECTS.
The last but not least is that the program will take place in a magical land, Ioannina the capital of Epirus. Set on the western shore of the lovely Lake Pamvotis, Ioannina is one of northern Greece's most atmospheric cities, and one of its more cultured and wealthy, as it was famous throughout the Ottoman Empire for its silver artisans, is offered for exploration.
Applications are open.
For more information and entry requirements please visit: https://ds4health.uoi.gr/
About the Department of Materials Science and Engineering of University of Ioannina
The Department of Materials Science and Engineering was established in 1999 and belongs to the School of Engineering by providing 5 years of high-level education and training in Materials Science and Technology. The Unit of Medical Technology and Intelligent Information Systems (MedLab) which belongs to the Department of Materials Science and Engineering is a highly innovative and self-contained research unit strongly activated in the fields of Biomedical Engineering and development of Intelligent Information systems. It has an internationally acknowledged excellence in conducting high quality scientific research and developing innovative Information Technology (IT) applications, products, and services.
About the Faculty of Medicine
The Faculty of Medicine of the School of Health Sciences of the University of Ioannina was established in 1977 and recently has been highly recognized since has been ranked 1st among all Medical Faculties in Greek Tertiary Education, according to the University of Leiden Ranking (the Netherlands) for 2019, as well as for the 2018 and the 2017.
About the Foundation for Research and Technology - Hellas (FORTH)
The Foundation for Research and Technology - Hellas (FORTH) was founded in 1983. It is one of the largest research centers in Greece with well-organized facilities, highly qualified personnel, and a reputation as a top-level research institution worldwide. FORTH comprises ten Research Institutes. Its headquarters and central administration are based in Heraklion, Crete. In Ioannina Biomedical Research Institute (BRI) of the Foundation for Research and Technology (FORTH) was established at Ioannina in 1998 as an independent institute. In 2001, BRI joined the Foundation for Research and Technology (FORTH), becoming its seventh Institute. Research in BRI focuses in basic molecular and cellular biology areas of biomedical research with high interest in public health and biomedicine.
Vasiliki Tsitsou
Univeristy of Ioannina
+30 697 187 8099
email us here
Visit us on social media:
X
Other
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 hours ago
- Yahoo
GSK reports improved outlook despite US drug tariffs
British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, despite US tariffs, after sales of its cancer drugs jumped in the second quarter. GSK, which makes medicines in the European Union as well as in Britain and the United States, said its guidance took into account "the European tariffs indicated this week". The EU-US trade deal reached at the weekend set a 15 percent tariff on most European Union goods imported into the United States, though it is thought that Washington could still take steps that would see medicines face a higher levy. Despite the backdrop, GSK chief executive Emma Walmsley said the group expected to be "towards the top end of" its financial guidance for 2025 and remained "confident" over the longer term. "GSK's strong momentum in 2025 continues with another quarter of excellent performance driven mainly by specialty medicines, our largest business, with double-digit sales growth in respiratory, immunology and inflammation, oncology and HIV," she added in a statement. Addressing an online press conference later Wednesday, Walmsley said GSK was "very well positioned" to increasingly supply the United States, its "number one priority market", from within the country. "Our overall planned investment in the US is in the tens of billions of dollars over the next five years," she added. The company said net profit jumped 23 percent to £1.44 billion ($1.92 billion) in the three months to the end of June compared with the second quarter in 2024. Group sales increased one percent to £8 billion, helped by a 36 percent increase in cancer treatments that offset falls for other drugs, including for influenza. Just over half of total revenue was earned in the US market during the second quarter. "The prognosis for GSK is looking positive," said Derren Nathan, head of equity research at Hargreaves Lansdown. "It hasn't let itself get too distracted by tariff uncertainty, with both second-quarter sales and earnings coming in ahead of market forecasts," he said. GSK shares advanced 1.0 percent in afternoon deals on the London stock exchange, bucking a downward trend on the benchmark FTSE 100 index. ode-bcp/ajb/js
Yahoo
a day ago
- Yahoo
Leading European Shipbuilder Selects Aino's SaaS Platform
Aino Health AB (publ) has signed an agreement with one of Europe's leading shipbuilding companies for the implementation of the Aino SaaS platform. The agreement covers 2,000 employees and aims to strengthen the customer's proactive work ability management and employee well-being initiatives. 'We are proud that our platform will support this organization in improving work ability and reducing health-related risks across their operations,' says Jyrki Eklund, CEO of Aino Health. Through the Aino platform, the customer will gain access to real-time data, automated early support processes, and root cause analysis tools – all designed to reduce sick leave and improve productivity. The implementation will begin during Q3 2025 with a phased rollout across production and administrative functions. The agreement aligns with Aino Health's strategic focus on the manufacturing industry and further strengthens the company's position in the European market. For more information Jyrki Eklund CEO Aino HealthPhone: +358 40 042 Certified adviser DNB Carnegie Investment Bank ABMore info: Aino Health (publ) Aino Health is the leading provider of Software as a Service (SaaS) solutions for Corporate health Management. Our comprehensive platform offers data-driven insights to enhance work ability, well-being and productivity, fostering high-performing organizations. By making health and wellness an integrated part of daily operations, we help reduce sickness absences, identify root causes of health challenges, and systematize proactive support for employees. For more information, please visit in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Veolia Heads a Groundbreaking Wastewater Epidemiological Surveillance Across Europe
Wastewater analysis is a key tool for anticipating health risks, triggering preventive measures earlier, and thus strengthening the effectiveness of public health responses. Thanks to its specialized laboratories, Veolia will analyze up to 500 wastewater samples, each subjected to more than 500 different tests, in order to detect emerging health threats at an early stage. This surveillance is part of the EU4Health pioneering program, led by HaDEA (European Health and Digital Executive Agency - European Commission), aimed at monitoring the health status of the Europeans across major cities across the continent. PARIS, July 30, 2025--(BUSINESS WIRE)--Regulatory News: Veolia (PARIS:VIE), the world leader in water technologies, is at the helm of a groundbreaking European epidemiological surveillance program that leverages wastewater as a real-time health indicator. The goal: detect emerging threats early and protect urban populations across the continent. Veolia will oversee the monitoring aspect of this three-year program and will analyze up to 500 wastewater samples collected from European cities in its laboratories in Spain. Each sample will undergo more than 500 in-depth analyses, targeting a wide range of pollutants, viruses, bacteria, and drug residues. This initiative is aligned with the revised European directive on wastewater treatment, which formally embeds epidemiological surveillance as a pillar of public health. It is also part of the European "One Health" strategy, which will enable the analysis of collective behavior, the assessment of the impact of public policies, and the identification of new threats, while strengthening Europe's health sovereignty. This principle was recently reiterated in the European Strategy for Water Resilience. Estelle Brachlianoff, CEO of Veolia said: "Being a pioneer means anticipating tomorrow's challenges, and that's exactly what we're doing here, by transforming wastewater into an early warning tool on a European scale. This project is a concrete embodiment of our GreenUp strategic plan: our environmental solutions are also solutions for the health of citizens and the resilience of European territories. We are delighted to be able to bring the Group's expertise in water treatment and environmental health to the European Union, and to pave the way for a more connected, intelligent, and preventive public health system." The project is led by Veolia, in partnership with the CSIC (Spanish National Research Council), Cetaqua (Veolia Water Technology Center), and the University of Santiago de Compostela. It is based on more than ten years of field experience in wastewater monitoring in Madrid, Barcelona, and Seville, covering nearly a third of the Spanish population. Daniel Tugues, CEO of Veolia Spain, said: "The Covid-19 pandemic has revealed the untapped potential of wastewater for public health monitoring. This project puts that learning into practice on a large scale. We are very proud that the expertise of our teams is recognized at the European level. Thanks to this project, Spain is at the forefront of a new approach to environmental health, combining scientific rigor, technological innovation, and a commitment to the common good." ABOUT VEOLIA Veolia group aims to become the benchmark company for ecological transformation. Present on five continents with 215,000 employees, the Group designs and deploys useful, practical solutions for the management of water, waste and energy that are contributing to a radical turnaround of the current situation. Through its three complementary activities, Veolia helps to develop access to resources, to preserve available resources and to renew them. In 2024, the Veolia group provided 111 million inhabitants with drinking water and 98 million with sanitation, produced 42 million megawatt hours of energy and treated 65 million tonnes of waste. Veolia Environnement (Paris Euronext: VIE) achieved consolidated revenue of 44.7 billion euros in 2024. View source version on Contacts PRESS RELATIONS Laurent Obadia - Evgeniya Mazalova Anna Beaubatie - Aurélien Sarrosquy Charline Bouchereau Tel.+ 33 (0) 1 85 57 86 INVESTORS RELATIONS Selma Bekhechi - Ariane de Lamaze Tel. + 33 (0)1 85 57 84 76investor-relations@ Sign in to access your portfolio
